mbs303MBS 303 is a bispecific antibody targeting CD3CD20 being developed by Beijing Mabworks Biotech for the treatment of B cell non-Hodgkin lymphoma. TheMBS303-B-AX-0RAA Vitrohm Resistor Hardware Dummy pin datasheet, inventory & pricing.